Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia

Yuan Hung Yeh, Junn Liang Chang, Pei Ching Hsiao, Shih Ming Tsao, Chien Huang Lin, Shang Jyh Kao, Ming Chih Chou, Shun Fa Yang, Ming Hsien Chien

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: The aim of this study was to investigate the differential plasma levels of lipocalin 2 (LCN2) and its complex with MMP-9 (where MMP is matrix metalloproteinase) before and after antibiotic treatment in hospitalized adult patients with community-acquired pneumonia (CAP). Method: Plasma LCN2 and LCN2/MMP-9 complex levels were measured in 61 adult patients with CAP and 60 healthy controls using commercial enzyme-linked immunosorbent assay (ELISA). Results: A decrease in the number of white blood cells (WBCs) and neutrophils and decreases in the levels of C-reactive protein (CRP), LCN2, and LCN2/MMP-9 complex were observed after antibiotic treatment. The plasma level of LCN2, but not that of CRP, was correlated with the severity of CAP based on the Pneumonia Severity Index (PSI; r = 0.333, P = 0.009), confusion, urea, respiratory rate and blood pressure (CURB)-65 (r = 0.288, P = 0.024), and Acute Physiology And Chronic Health Evaluation II (APACHE II) scores (r = 0.328, P = 0.010). LCN2 levels were also significantly correlated with LCN2/MMP-9 levels and the numbers of WBCs or neutrophils. Conclusions: Plasma levels of LCN2 and the LCN2/MMP-9 complex can act as adjuvant diagnostic biomarkers for CAP. Plasma LCN2 might play a further role in the clinical assessment of the severity of CAP, which could potentially guide the development of future treatment strategies.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalJournal of Clinical Laboratory Analysis
Volume27
Issue number4
DOIs
Publication statusPublished - Jul 2013

    Fingerprint

Keywords

  • Community-acquired pneumonia
  • Lipocalin 2
  • Matrix metalloprotease-9
  • Pneumonia Severity Index

ASJC Scopus subject areas

  • Medical Laboratory Technology
  • Microbiology (medical)
  • Immunology and Allergy
  • Hematology
  • Public Health, Environmental and Occupational Health
  • Biochemistry, medical
  • Clinical Biochemistry

Cite this